Medliminal, LLC – Trademark Portfolio
Entity Type: 16
Medliminal, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include EMBC, H-CAT, MEDLIMINAL EMBC EMPLOYEE MEDICAL BILL CHAMPION, and M MEDLIMINAL THE LEADING EDGE OF MEDICAL COST CONTAINMENT. The owner is based in Manassas, VA.
9385 Innovation Drive
Manassas, VA 20110
Showing of trademarks Trademarks
Trademark Classifications
Medliminal, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Medliminal, LLC have?
Medliminal, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.
What trademark classes does Medliminal, LLC file in?
Medliminal, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 38 (Telecommunications). Class 35 covers advertising; business management; business administration; office functions.
What are Medliminal, LLC's most well-known trademarks?
Medliminal, LLC's registered trademark portfolio includes well-known marks such as EMBC, H-CAT, MEDLIMINAL EMBC EMPLOYEE MEDICAL BILL CHAMPION, and M MEDLIMINAL THE LEADING EDGE OF MEDICAL COST CONTAINMENT. These are among 5 currently registered trademarks in the portfolio.
What is Medliminal, LLC's trademark registration success rate?
Medliminal, LLC has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.